Review




Structured Review

Caliper Life Sciences ivis kinetic imaging system
Ivis Kinetic Imaging System, supplied by Caliper Life Sciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ivis+kinetic+imaging+system/pm42115216-413-5-9?v=Caliper+Life+Sciences
Average 86 stars, based on 1 article reviews
ivis kinetic imaging system - by Bioz Stars, 2026-08
86/100 stars

Images



Similar Products

86
Caliper Life Sciences ivis kinetic imaging system
Ivis Kinetic Imaging System, supplied by Caliper Life Sciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ivis+kinetic+imaging+system/pm42115216-413-5-9?v=Caliper+Life+Sciences
Average 86 stars, based on 1 article reviews
ivis kinetic imaging system - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

96
Revvity ivis kinetic imaging system
Ivis Kinetic Imaging System, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ivis+kinetic+imaging+system/pmc12892532-194-19-23?v=Revvity
Average 96 stars, based on 1 article reviews
ivis kinetic imaging system - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

86
Caliper Life Sciences ivis kinetic fluorescence imaging system
Ivis Kinetic Fluorescence Imaging System, supplied by Caliper Life Sciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ivis+kinetic+imaging+system/pm24941029__ja503939n_si_001-193-14-19?v=Caliper+Life+Sciences
Average 86 stars, based on 1 article reviews
ivis kinetic fluorescence imaging system - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

96
Revvity ivis kinetic
Ivis Kinetic, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ivis+kinetic+imaging+system/pm29470072__nl7b03813_si_001-164-14-16?v=Revvity
Average 96 stars, based on 1 article reviews
ivis kinetic - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

96
Revvity ivis kinetic instrument
( A ) Schematic showing comparison of AAV9 vectors packaging either the strong, constitutively active chicken beta actin (CBA) promoter or minimal Heat shock protein 1a ( Hsp1a ) promoter to direct fLuc expression. n=5 mice/AAV group. ( B ) Representative <t>IVIS</t> images of mice injected with AAV containing either CBA (top) or Hsp1a (bottom) promoters. Red boxes indicate regions of interest (ROIs) marking cardiac, liver, and whole-body expression. ( C ) Average radiance measured from cardiac ROIs from CBA (top) or Hsp1a (bottom) promoters shows relatively consistent expression from 30 to 68 days post-AAV injection. Square, male mice. Circle, female mice. ( D, E ) Average radiance measured from liver ( D ) and whole-body ( E ) ROIs showed relatively consistent levels of expression over time for both promoters.
Ivis Kinetic Instrument, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ivis+kinetic+imaging+system/pmc12431772-194-7-14?v=Revvity
Average 96 stars, based on 1 article reviews
ivis kinetic instrument - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

96
Revvity ivis kinetic optical system
( A ) Schematic showing comparison of AAV9 vectors packaging either the strong, constitutively active chicken beta actin (CBA) promoter or minimal Heat shock protein 1a ( Hsp1a ) promoter to direct fLuc expression. n=5 mice/AAV group. ( B ) Representative <t>IVIS</t> images of mice injected with AAV containing either CBA (top) or Hsp1a (bottom) promoters. Red boxes indicate regions of interest (ROIs) marking cardiac, liver, and whole-body expression. ( C ) Average radiance measured from cardiac ROIs from CBA (top) or Hsp1a (bottom) promoters shows relatively consistent expression from 30 to 68 days post-AAV injection. Square, male mice. Circle, female mice. ( D, E ) Average radiance measured from liver ( D ) and whole-body ( E ) ROIs showed relatively consistent levels of expression over time for both promoters.
Ivis Kinetic Optical System, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ivis+kinetic+imaging+system/us12410260-227-1-4?v=Revvity
Average 96 stars, based on 1 article reviews
ivis kinetic optical system - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

96
Revvity ivis kinetic system
( A ) Schematic showing comparison of AAV9 vectors packaging either the strong, constitutively active chicken beta actin (CBA) promoter or minimal Heat shock protein 1a ( Hsp1a ) promoter to direct fLuc expression. n=5 mice/AAV group. ( B ) Representative <t>IVIS</t> images of mice injected with AAV containing either CBA (top) or Hsp1a (bottom) promoters. Red boxes indicate regions of interest (ROIs) marking cardiac, liver, and whole-body expression. ( C ) Average radiance measured from cardiac ROIs from CBA (top) or Hsp1a (bottom) promoters shows relatively consistent expression from 30 to 68 days post-AAV injection. Square, male mice. Circle, female mice. ( D, E ) Average radiance measured from liver ( D ) and whole-body ( E ) ROIs showed relatively consistent levels of expression over time for both promoters.
Ivis Kinetic System, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ivis+kinetic+imaging+system/pm40914480-154-28-31?v=Revvity
Average 96 stars, based on 1 article reviews
ivis kinetic system - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

96
Revvity ivis lumina kinetic series iii imaging system
( A ) Schematic showing comparison of AAV9 vectors packaging either the strong, constitutively active chicken beta actin (CBA) promoter or minimal Heat shock protein 1a ( Hsp1a ) promoter to direct fLuc expression. n=5 mice/AAV group. ( B ) Representative <t>IVIS</t> images of mice injected with AAV containing either CBA (top) or Hsp1a (bottom) promoters. Red boxes indicate regions of interest (ROIs) marking cardiac, liver, and whole-body expression. ( C ) Average radiance measured from cardiac ROIs from CBA (top) or Hsp1a (bottom) promoters shows relatively consistent expression from 30 to 68 days post-AAV injection. Square, male mice. Circle, female mice. ( D, E ) Average radiance measured from liver ( D ) and whole-body ( E ) ROIs showed relatively consistent levels of expression over time for both promoters.
Ivis Lumina Kinetic Series Iii Imaging System, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ivis+kinetic+imaging+system/pmc12409480__SC-016-D5SC05331E-s001-18-9-8?v=Revvity
Average 96 stars, based on 1 article reviews
ivis lumina kinetic series iii imaging system - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

Image Search Results


( A ) Schematic showing comparison of AAV9 vectors packaging either the strong, constitutively active chicken beta actin (CBA) promoter or minimal Heat shock protein 1a ( Hsp1a ) promoter to direct fLuc expression. n=5 mice/AAV group. ( B ) Representative IVIS images of mice injected with AAV containing either CBA (top) or Hsp1a (bottom) promoters. Red boxes indicate regions of interest (ROIs) marking cardiac, liver, and whole-body expression. ( C ) Average radiance measured from cardiac ROIs from CBA (top) or Hsp1a (bottom) promoters shows relatively consistent expression from 30 to 68 days post-AAV injection. Square, male mice. Circle, female mice. ( D, E ) Average radiance measured from liver ( D ) and whole-body ( E ) ROIs showed relatively consistent levels of expression over time for both promoters.

Journal: eLife

Article Title: Spatial and longitudinal tracking of enhancer-AAV vectors that target transgene expression to injured mouse myocardium

doi: 10.7554/eLife.107148

Figure Lengend Snippet: ( A ) Schematic showing comparison of AAV9 vectors packaging either the strong, constitutively active chicken beta actin (CBA) promoter or minimal Heat shock protein 1a ( Hsp1a ) promoter to direct fLuc expression. n=5 mice/AAV group. ( B ) Representative IVIS images of mice injected with AAV containing either CBA (top) or Hsp1a (bottom) promoters. Red boxes indicate regions of interest (ROIs) marking cardiac, liver, and whole-body expression. ( C ) Average radiance measured from cardiac ROIs from CBA (top) or Hsp1a (bottom) promoters shows relatively consistent expression from 30 to 68 days post-AAV injection. Square, male mice. Circle, female mice. ( D, E ) Average radiance measured from liver ( D ) and whole-body ( E ) ROIs showed relatively consistent levels of expression over time for both promoters.

Article Snippet: Bioluminescence images were then collected using an IVIS Kinetic instrument and Living Image Software (PerkinElmer).

Techniques: Comparison, Expressing, Injection

( A ) Schematic illustration of study design. Albino BALB/c mice were systemically injected with AAV9 vectors packaging fLuc reporter cassettes directed by TREEs and a permissive promoter. Mice underwent ischemia/reperfusion (I/R) surgery at D61 and were imaged by IVIS at indicated time points. ( B ) Representative IVIS images indicate changes of expression over time and space for each vector. Cardiac region of interest (ROI) indicated by red box. n=2 mice. ( C ) Average radiance measured from cardiac ROIs plotted over days post-injury (dpi). Average radiance normalized to their baseline pre-injury was also plotted (right). n=2 mice. ( D ) Average cardiac radiance showed a transient increase in expression for both REN (left) and 2ankrd1aEN (right) after I/R injury, whereas sham-operated animals showed relatively constant expression. n=2 mice for I/R, n=3 mice for sham.

Journal: eLife

Article Title: Spatial and longitudinal tracking of enhancer-AAV vectors that target transgene expression to injured mouse myocardium

doi: 10.7554/eLife.107148

Figure Lengend Snippet: ( A ) Schematic illustration of study design. Albino BALB/c mice were systemically injected with AAV9 vectors packaging fLuc reporter cassettes directed by TREEs and a permissive promoter. Mice underwent ischemia/reperfusion (I/R) surgery at D61 and were imaged by IVIS at indicated time points. ( B ) Representative IVIS images indicate changes of expression over time and space for each vector. Cardiac region of interest (ROI) indicated by red box. n=2 mice. ( C ) Average radiance measured from cardiac ROIs plotted over days post-injury (dpi). Average radiance normalized to their baseline pre-injury was also plotted (right). n=2 mice. ( D ) Average cardiac radiance showed a transient increase in expression for both REN (left) and 2ankrd1aEN (right) after I/R injury, whereas sham-operated animals showed relatively constant expression. n=2 mice for I/R, n=3 mice for sham.

Article Snippet: Bioluminescence images were then collected using an IVIS Kinetic instrument and Living Image Software (PerkinElmer).

Techniques: Injection, Expressing, Plasmid Preparation

( A ) Schematic of experimental timeline, comparing AAV9 and AAV.cc84 capsids for systemic delivery of REN-Hsp1a:: fLuc. Mice were in vivo bioluminescence imaging (IVIS) imaged in the weeks following AAV delivery and post-sham surgery. ( B ) Representative IVIS images of mice injected with either AAV9 (left) or AAV.cc84 (right) at 14 (top) and 21 days (bottom) post-AAV injection. Mice were also subdivided by biological sex to account for sex differences in AAV liver tropism. ( C ) Average radiance from liver regions of interest (ROIs) showed significantly higher expression in AAV9-transduced mice compared to AAV.cc84 through all timepoints (n=6 mice, Holm–Sidak multiple comparisons test). ( D ) Representative IVIS images of harvested organs at 42 days post-AAV demonstrate liver expression with AAV9 (left) while undetected with AAV.cc84 (right). ( E ) Vector genome quantification from collected liver samples reveals higher liver transduction with AAV9 compared to AAV.cc84 for both female and male mice.

Journal: eLife

Article Title: Spatial and longitudinal tracking of enhancer-AAV vectors that target transgene expression to injured mouse myocardium

doi: 10.7554/eLife.107148

Figure Lengend Snippet: ( A ) Schematic of experimental timeline, comparing AAV9 and AAV.cc84 capsids for systemic delivery of REN-Hsp1a:: fLuc. Mice were in vivo bioluminescence imaging (IVIS) imaged in the weeks following AAV delivery and post-sham surgery. ( B ) Representative IVIS images of mice injected with either AAV9 (left) or AAV.cc84 (right) at 14 (top) and 21 days (bottom) post-AAV injection. Mice were also subdivided by biological sex to account for sex differences in AAV liver tropism. ( C ) Average radiance from liver regions of interest (ROIs) showed significantly higher expression in AAV9-transduced mice compared to AAV.cc84 through all timepoints (n=6 mice, Holm–Sidak multiple comparisons test). ( D ) Representative IVIS images of harvested organs at 42 days post-AAV demonstrate liver expression with AAV9 (left) while undetected with AAV.cc84 (right). ( E ) Vector genome quantification from collected liver samples reveals higher liver transduction with AAV9 compared to AAV.cc84 for both female and male mice.

Article Snippet: Bioluminescence images were then collected using an IVIS Kinetic instrument and Living Image Software (PerkinElmer).

Techniques: In Vivo, Imaging, Injection, Expressing, Plasmid Preparation, Transduction

( A ) Representative in vivo bioluminescence imaging (IVIS) images of mice injected with either AAV9 (left) or AAV.cc84 (right) at 7 (top) and 35 days (bottom) post-AAV injection. ( B ) Average radiance in the heart was similar between AAV9 and AAV.cc84 (n=6 mice, Holm–Sidak multiple comparisons test). ( C ) Vector genome quantification from cardiac tissues showed similar levels of vector genomes between AAV9 and AAV.cc84 for both sexes (n=3 mice, Holm–Sidak multiple comparisons test). ( D ) Representative IVIS images of mice with regions of interest (ROIs) used to measure expression in head/neck and lower abdomen (white dashed box). ( E ) Average radiance measured in the head/neck (left) and lower abdomen (right) was similar between AAV9 and AAV.cc84 over the course of the study (n=6 mice, Holm–Sidak multiple comparisons test).

Journal: eLife

Article Title: Spatial and longitudinal tracking of enhancer-AAV vectors that target transgene expression to injured mouse myocardium

doi: 10.7554/eLife.107148

Figure Lengend Snippet: ( A ) Representative in vivo bioluminescence imaging (IVIS) images of mice injected with either AAV9 (left) or AAV.cc84 (right) at 7 (top) and 35 days (bottom) post-AAV injection. ( B ) Average radiance in the heart was similar between AAV9 and AAV.cc84 (n=6 mice, Holm–Sidak multiple comparisons test). ( C ) Vector genome quantification from cardiac tissues showed similar levels of vector genomes between AAV9 and AAV.cc84 for both sexes (n=3 mice, Holm–Sidak multiple comparisons test). ( D ) Representative IVIS images of mice with regions of interest (ROIs) used to measure expression in head/neck and lower abdomen (white dashed box). ( E ) Average radiance measured in the head/neck (left) and lower abdomen (right) was similar between AAV9 and AAV.cc84 over the course of the study (n=6 mice, Holm–Sidak multiple comparisons test).

Article Snippet: Bioluminescence images were then collected using an IVIS Kinetic instrument and Living Image Software (PerkinElmer).

Techniques: In Vivo, Imaging, Injection, Plasmid Preparation, Expressing

( A ) Schematic of experimental timeline comparing expression between Hsp1a and 2ankrd1aEN when delivered at 4 dpi. ( B ) Representative in vivo bioluminescence imaging (IVIS) images of mice injected with Hsp1a (top) or 2ankrd1aEN- Hsp1a (bottom) after ischemia/reperfusion (I/R) injury. ( C ) Cardiac average radiance normalized to the 7 dpi time point increased over time with 2ankrd1aEN while remaining stable with Hsp1a (n=4 mice, Holm–Sidak multiple comparisons test). ( D ) Average cardiac radiance directed by 2ankrd1aEN was significantly higher in mice with I/R injury compared to sham at 7 dpi (n=4 mice, Welch’s t -test). ( E ) Average cardiac radiance was more significantly elevated in the first 21 days post-injury in mice with I/R injury compared to sham (n=4 mice, Mann–Whitney tests).

Journal: eLife

Article Title: Spatial and longitudinal tracking of enhancer-AAV vectors that target transgene expression to injured mouse myocardium

doi: 10.7554/eLife.107148

Figure Lengend Snippet: ( A ) Schematic of experimental timeline comparing expression between Hsp1a and 2ankrd1aEN when delivered at 4 dpi. ( B ) Representative in vivo bioluminescence imaging (IVIS) images of mice injected with Hsp1a (top) or 2ankrd1aEN- Hsp1a (bottom) after ischemia/reperfusion (I/R) injury. ( C ) Cardiac average radiance normalized to the 7 dpi time point increased over time with 2ankrd1aEN while remaining stable with Hsp1a (n=4 mice, Holm–Sidak multiple comparisons test). ( D ) Average cardiac radiance directed by 2ankrd1aEN was significantly higher in mice with I/R injury compared to sham at 7 dpi (n=4 mice, Welch’s t -test). ( E ) Average cardiac radiance was more significantly elevated in the first 21 days post-injury in mice with I/R injury compared to sham (n=4 mice, Mann–Whitney tests).

Article Snippet: Bioluminescence images were then collected using an IVIS Kinetic instrument and Living Image Software (PerkinElmer).

Techniques: Expressing, In Vivo, Imaging, Injection, MANN-WHITNEY

( A ) Ischemia/reperfusion (I/R) surgery injury extent was assessed by ejection fraction via echocardiography to estimate injury prior to AAV delivery (n=4 mice). ( B ) Cardiac average radiance plotted for each individual mouse with I/R injury plotted over time with either Hsp1a:: fLuc (gray) or 2ankrd1aEN- Hsp1a:: fLuc (black). ( C ) Representative in vivo bioluminescence imaging (IVIS) images of sham-operated mice injected with AAV.cc84 packaged with 2ankrd1aEN- Hsp1a:: fLuc.

Journal: eLife

Article Title: Spatial and longitudinal tracking of enhancer-AAV vectors that target transgene expression to injured mouse myocardium

doi: 10.7554/eLife.107148

Figure Lengend Snippet: ( A ) Ischemia/reperfusion (I/R) surgery injury extent was assessed by ejection fraction via echocardiography to estimate injury prior to AAV delivery (n=4 mice). ( B ) Cardiac average radiance plotted for each individual mouse with I/R injury plotted over time with either Hsp1a:: fLuc (gray) or 2ankrd1aEN- Hsp1a:: fLuc (black). ( C ) Representative in vivo bioluminescence imaging (IVIS) images of sham-operated mice injected with AAV.cc84 packaged with 2ankrd1aEN- Hsp1a:: fLuc.

Article Snippet: Bioluminescence images were then collected using an IVIS Kinetic instrument and Living Image Software (PerkinElmer).

Techniques: In Vivo, Imaging, Injection

( A ) Representative in vivo bioluminescence imaging (IVIS) images of mice with sham (top) or (bottom) surgery transduced with either AAV9 (left) or IR41 (right) packaged with 2ankrd1aEN- Hsp1a:: fLuc (n=3–4 mice). ( B, C ) Cardiac average ( B ) and maximum ( C ) radiance was elevated in MI mice transduced with IR41 compared to AAV9 (n=3–4 mice, Holm–Sidak multiple comparisons test). ( D ) Viral genome quantification from heart tissues was elevated in MI mice injected with IR41 compared to AAV9 (n=3–4 mice, Holm–Sidak multiple comparisons test).

Journal: eLife

Article Title: Spatial and longitudinal tracking of enhancer-AAV vectors that target transgene expression to injured mouse myocardium

doi: 10.7554/eLife.107148

Figure Lengend Snippet: ( A ) Representative in vivo bioluminescence imaging (IVIS) images of mice with sham (top) or (bottom) surgery transduced with either AAV9 (left) or IR41 (right) packaged with 2ankrd1aEN- Hsp1a:: fLuc (n=3–4 mice). ( B, C ) Cardiac average ( B ) and maximum ( C ) radiance was elevated in MI mice transduced with IR41 compared to AAV9 (n=3–4 mice, Holm–Sidak multiple comparisons test). ( D ) Viral genome quantification from heart tissues was elevated in MI mice injected with IR41 compared to AAV9 (n=3–4 mice, Holm–Sidak multiple comparisons test).

Article Snippet: Bioluminescence images were then collected using an IVIS Kinetic instrument and Living Image Software (PerkinElmer).

Techniques: In Vivo, Imaging, Transduction, Injection

( A ) Compiled in vivo bioluminescence imaging (IVIS) images of mice that underwent sham or MI surgery with AAV9 or IR41 transduced at 3 dpi. Mice were imaged at 7, 14, and 21 dpi. ( B, C ) Cardiac average ( B ) and maximum ( C ) radiance were statistically similar between AAV9 and IR41 in sham-operated mice.

Journal: eLife

Article Title: Spatial and longitudinal tracking of enhancer-AAV vectors that target transgene expression to injured mouse myocardium

doi: 10.7554/eLife.107148

Figure Lengend Snippet: ( A ) Compiled in vivo bioluminescence imaging (IVIS) images of mice that underwent sham or MI surgery with AAV9 or IR41 transduced at 3 dpi. Mice were imaged at 7, 14, and 21 dpi. ( B, C ) Cardiac average ( B ) and maximum ( C ) radiance were statistically similar between AAV9 and IR41 in sham-operated mice.

Article Snippet: Bioluminescence images were then collected using an IVIS Kinetic instrument and Living Image Software (PerkinElmer).

Techniques: In Vivo, Imaging